Importance of Asparagine 202 in Manipulating Active Site Structure and Substrate Preference for Human CYP17A1

被引:5
|
作者
Liu, Yilin [1 ]
Denisov, Ilia [2 ,3 ]
Gregory, Michael [2 ,3 ]
Sligar, Stephen G. [2 ,3 ]
Kincaid, James R. [1 ]
机构
[1] Marquette Univ, Dept Chem, Milwaukee, WI 53233 USA
[2] Univ Illinois, Dept Chem, Urbana, IL 61801 USA
[3] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA
基金
美国国家卫生研究院;
关键词
NEONATAL PIG TESTIS; CYTOCHROME P450CAM; PROTON DELIVERY; MICROSOMAL CYTOCHROME-P-450; HYDROPEROXO INTERMEDIATE; ANDROGEN FORMATION; MECHANISM; HYDROXYLATION; 17,20-LYASE; RESONANCE;
D O I
10.1021/acs.biochem.2c00023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The multifunctional cytochrome P450 17A1 (CYP17A1) plays a crucial role in human steroid hormone synthesis (UniProtKB-P05093). It first carries out standard monooxygenase chemistry, converting pregnenolone (PREG) and progesterone (PROG) into 17OH-PREG and 17OH-PROG, utilizing a "Compound I" to initiate hydrogen abstraction and radical recombination in the classic "oxygen rebound" mechanism. Additionally, these hydroxylated products also serve as substrates in a second oxidative cycle which cleaves the 17-20 carbon-carbon bond to form dehydroepiandroster-one and androstenedione, which are key precursors in the generation of powerful androgens and estrogens. Interestingly, in humans, with 17OH-PREG, this so-called lyase reaction is more efficient than with 17OH-PROG, based on Kcat/Km values. In the present work, the asparagine residue at 202 position was replaced by serine, an alteration which can affect substrate orientation and control substrate preference for the lyase reaction. First, we report studies of solvent isotope effects for the N202S CYP17A1 mutant in the presence of 17OH-PREG and 17OH-PROG, which suggest that the ferric peroxo species is the predominant catalytically active intermediate in the lyase step. This conclusion is further supported by employing a combination of cryoradiolysis and resonance Raman techniques to successfully trap and structurally characterize the key reaction intermediates, including the peroxo, the hydroperoxo, and the crucial peroxo-hemiketal intermediate. Collectively, these studies show that the mutation causes active site structural changes that alter the H-bonding interactions with the key Fe-O-O fragment and the degree of protonation of the reactive ferric peroxo intermediate, thereby impacting lyase efficiency.
引用
收藏
页码:583 / 594
页数:12
相关论文
共 50 条
  • [1] Human P450 CYP17A1: Control of Substrate Preference by Asparagine 202
    Gregory, Michael C.
    Mak, Piotr J.
    Khatri, Yogan
    Kincaid, James R.
    Sligar, Stephen G.
    BIOCHEMISTRY, 2018, 57 (05) : 764 - 771
  • [2] Active site proton delivery and the lyase activity of human CYP17A1
    Khatri, Yogan
    Gregory, Michael C.
    Grinkova, Yelena V.
    Denisov, Ilia G.
    Sligar, Stephen G.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 443 (01) : 179 - 184
  • [3] Secondary Binding Site of CYP17A1 in Enhanced Sampling Simulations
    Wrobel, Tomasz M.
    Bartuzi, Damian
    Kaczor, Agnieszka A.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2024, 64 (19) : 7679 - 7686
  • [4] IN SILICO ANALYSIS OF THE PHOSPHORYLATION EFFECT ON THE STRUCTURE OF THE HUMAN STEROL-HYDROXYLASES CYP17A1 AND CYP19A1
    Dzichenka, Yaraslau U.
    Trawkina, Maria
    Yantsevich, Aliaksei, V
    Usanov, Sergei A.
    DOKLADY NATSIONALNOI AKADEMII NAUK BELARUSI, 2020, 64 (04): : 431 - 440
  • [5] CYP17A1 and CYP21A2, enzymology and their human deficiency states
    Auchus, Richard J.
    DRUG METABOLISM REVIEWS, 2011, 43 : 9 - 10
  • [6] Human Cytochrome CYP17A1: The Structural Basis for Compromised Lyase Activity with 17-Hydroxyprogesterone
    Mak, Piotr J.
    Duggal, Ruchia
    Denisov, Ilia G.
    Gregory, Michael C.
    Sligar, Stephen G.
    Kincaid, James R.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2018, 140 (23) : 7324 - 7331
  • [7] INTRACRINE DYNAMICS OF CYP17A1 ACTIVITIES IN HUMAN CASTRATION RESISTANT PROSTATE CANCER
    Kosaka, Takeo
    Miyajima, Akira
    Maeda, Takahiro
    Nagata, Hirohiko
    Yasumizu, Yota
    Kikuchi, Eiji
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2013, 189 (04): : E207 - E208
  • [8] Interaction of 17α-hydroxylase, 17(20)-lyase (CYP17A1) inhibitors - abiraterone and galeterone - with human sterol 14α-demethylase (CYP51A1)
    Masamrekh, Rami
    Kuzikov, Alexey
    Veselovsky, Alexander
    Toropygin, Iliya
    Shkel, Tatsiana
    Strushkevich, Natalia
    Gilep, Andrei
    Usanov, Sergey
    Archakov, Alexander
    Shumyantseva, Victoria
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2018, 186 : 24 - 33
  • [9] Limited in vitro efficacy of CYP17A1 inhibition on human castration resistant prostate cancer
    Kosaka, Takeo
    Miyajima, Akira
    Yasumizu, Yota
    Miyazaki, Yasumasa
    Kikuchi, Eiji
    Oya, Mototsugu
    STEROIDS, 2014, 92 : 39 - 44
  • [10] A rare intronic mutation in the splice acceptor site of the CYP17A1 gene in a patient with 17α-hydroxylase/17,20-lyase deficiency
    Guo, Xudong
    Wang, Hanbo
    Xiang, Yuzhu
    Ren, Xiangbin
    Jiang, Shaobo
    GYNECOLOGICAL ENDOCRINOLOGY, 2021, 37 (01) : 97 - 100